186 related articles for article (PubMed ID: 3905594)
1. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP
IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594
[TBL] [Abstract][Full Text] [Related]
2. Massive therapy and autologous bone marrow transplantation in very bad prognosis Burkitt's lymphoma.
Philip T; Biron P; Philip I; Favrot M; Souillet G; Philippe N; Hervé P; Plouvier E; Bernard JL; Raybaud C
IARC Sci Publ; 1985; (60):419-34. PubMed ID: 3905593
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K
Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
[TBL] [Abstract][Full Text] [Related]
4. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
5. Massive chemotherapy and autologous bone marrow transplantation in Burkitt's lymphoma: the first two patients successfully treated in Thailand.
Suvatte V; Issaragrisil S; Chandanayingyong D; Mahasandana C; Tanphaichitr VS; Jirapinyo P
J Med Assoc Thai; 1990 Oct; 73(10):572-80. PubMed ID: 2280205
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations.
Gorin NC; Douay L; Laporte JP; Lopez M; Zittoun R; Rio B; David R; Stachowiak J; Jansen J; Cazellas P
Cancer Treat Rep; 1985 Sep; 69(9):953-9. PubMed ID: 3896482
[TBL] [Abstract][Full Text] [Related]
7. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
[TBL] [Abstract][Full Text] [Related]
8. [Autologous bone marrow transplantation in Burkitt's lymphoma].
de Terlizzi M; Philip T; Biron P; Philip I; Frappaz D; Pinkerton R; Souillet G; Bernard JL; Laporte JP; Philippe N
Minerva Pediatr; 1987 Oct; 39(19):739-49. PubMed ID: 3325797
[No Abstract] [Full Text] [Related]
9. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
11. [Autologous bone marrow transplantation in a case of Burkitt's lymphoma].
Yamada K; Shinohara K; Inoue M; Fujii Y; Yoshizaki Y; Kaneko T; Matsumoto N
Rinsho Ketsueki; 1985 Jan; 26(1):91-5. PubMed ID: 3889403
[No Abstract] [Full Text] [Related]
12. Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeads.
Stoppa AM; Hirn J; Blaise D; Delaage M; Novakovitch G; Viens P; Capiello MA; Mannoni P; Mawas C; Maraninchi D
Bone Marrow Transplant; 1990 Nov; 6(5):301-7. PubMed ID: 2291992
[TBL] [Abstract][Full Text] [Related]
13. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
14. Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.
Cohen Y; Amir G; Rachmilewitz EA; Polliack A
Haematologica; 2002 Jan; 87(1):ELT04. PubMed ID: 11801488
[No Abstract] [Full Text] [Related]
15. [A successful case of Burkitt's lymphoma treated with allogeneic bone marrow transplantation].
Hiraiwa A; Yoshikawa S; Sao H; Yamauchi T; Minami S; Yoshikawa H; Kodera Y; Akao Y; Naito K; Yamada K
Rinsho Ketsueki; 1986 Apr; 27(4):600-5. PubMed ID: 3525889
[No Abstract] [Full Text] [Related]
16. Prolonged disease-free survival after ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma.
Da WM; Zhong JT; Liu Y; Huang YS; Bai H; Wu XX; Ou YX; Wang CB; Xu SF
Chin Med J (Engl); 1993 Apr; 106(4):277-81. PubMed ID: 8325155
[TBL] [Abstract][Full Text] [Related]
17. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
Reece DE; Barnett MJ; Connors JM; Klingemann HG; O'Reilly SE; Shepherd JD; Sutherland HJ; Phillips GL
Bone Marrow Transplant; 1993 Feb; 11(2):139-46. PubMed ID: 8435663
[TBL] [Abstract][Full Text] [Related]
20. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]